Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation

BackgroundThe introduction of non–vitamin K antagonist oral anticoagulants has been a major advance for stroke prevention in atrial fibrillation; however, outcomes achieved in clinical trials may not translate to routine practice. We aimed to evaluate the effectiveness and safety of dabigatran, riva...

Descrición completa

Detalles Bibliográficos

Principais autores:	Xiaoxi Yao, Neena S. Abraham, Lindsey R. Sangaralingham, M. Fernanda Bellolio, Robert D. McBane, Nilay D. Shah, Peter A. Noseworthy
Formato:	Artigo
Idioma:	Inglês
Publicado:	Wiley 2016-06-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Assuntos:	atrial fibrillation bleeding non–vitamin K antagonist oral anticoagulants stroke warfarin
Acceso en liña:	https://www.ahajournals.org/doi/10.1161/JAHA.116.003725
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!